Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment ...

Good morning! Meta's elimination of fact-checking opens the door to misogynistic speech, Jane Fraser faces a test at Citi, ...

Eli Lilly & Company to establish new global capability centre in Hyderabad, recruiting over 1,000 professionals for advanced ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Havas is forging deeper into the GLP-1 space with a series of YouTube videos about the drug class and its impact on the world ...

LCCI Hyderabad will focus on scaling up Lilly’s innovation and efficiency by unlocking new technological advancements ...

To the Filipino doctor's utter dissapointment, he did not receive any financial compensation for his milestone discovery.

X will start adding parody labels to accounts and posts as the company tries to add some form of transparency to the platform ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Dr. Buchanan will helm Belharra's research organization as the company progresses its lead immunology and oncology programs, advances activities with its pharma collaborators, and enriches its ...